Characterization of JNJ-80948543, a Novel CD79bxCD20xCD3 Trispecific T-Cell Redirecting Antibody for the Treatment of B-Cell Non-Hodgkin Lymphoma

被引：15

作者：

Kuchnio, Anna ^{[1
]}

Yang, Danlin ^{[2
]}

Vloemans, Nele ^{[1
]}

Lowenstein, Cassandra ^{[2
]}

Cornelissen, Ivo ^{[1
]}

Amorim, Ricardo ^{[1
]}

Han, Chao ^{[2
]}

Sukumaran, Siddharth ^{[2
]}

Janssen, Lut ^{[1
]}

Suls, Toon ^{[1
]}

Bekkers, Mariette ^{[1
]}

Lasorsa, Elena ^{[1
]}

Fontana, Lorena ^{[1
]}

Medeiros, Nicole ^{[2
]}

Wu, Bingyuan ^{[2
]}

Chen, Jun ^{[2
]}

Feldkamp, Michael ^{[2
]}

Wu, Sheng-Jiun ^{[2
]}

Habte, Habtom ^{[2
]}

Krayer, John ^{[2
]}

Holland, Cam ^{[2
]}

Deyoung, M. Phillip ^{[2
]}

Elsayed, Yusri A. ^{[2
]}

Philippar, Ulrike ^{[1
]}

机构：

[1] Janssen Res & Dev, Beerse, Belgium

[2] Janssen Res & Dev, Spring House, PA USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-168739

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3105 / 3106

页数：2

共 50 条

[1] T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions
Russler-Germain, David A. A.
Ghobadi, Armin
FRONTIERS IN ONCOLOGY, 2023, 13
[2] Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple Myeloma
Pillarisetti, Ram
Yang, Danlin
Yao, Jianhong
Smith, Melissa
Luistro, Leopoldo
Vulfson, Peter
James, Testa, Jr.
Packman, Kathryn
Brodeur, Scott
Attar, Ricardo M.
Elsayed, Yusri
Philippar, Ulrike
BLOOD, 2023, 142
[3] Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
Sacchi, S
Federico, M
Dastoli, G
Fiorani, C
Vinci, G
Clò, V
Casolari, B
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 13 - 25
[4] Composite B-cell and T-cell non-Hodgkin lymphoma of the tibia
Kaleem, Z
McGuire, MH
Caracioni, AC
Leonard, RL
Pathan, MH
Lessmann, EA
Chan, WC
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (02) : 215 - 221
[5] CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma
Ghobadi, Armin
Bartlett, Nancy L.
LANCET, 2021, 398 (10306): : 1109 - 1110
[6] Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell
Liang, R
Todd, D
Ho, FCS
HEMATOLOGICAL ONCOLOGY, 1996, 14 (01) : 1 - 6
[7] Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma
Abramson, Jeremy S.
TRANSFUSION MEDICINE REVIEWS, 2020, 34 (01) : 29 - 33
[8] Anti-CD20 monoclonal antibody (rituximab) for therapy of T-cell/histiocyte-rich large B-cell non-Hodgkin lymphoma
Park, ES
Lim, JJ
Kang, HJ
Shin, HY
Ahn, HS
BLOOD, 2005, 106 (11) : 282B - 282B
[9] DARATUMUMAB, A NOVEL HUMAN CD38 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL NON-HODGKIN LYMPHOMA
Matas-Cespedes, A.
Vidal-Crespo, A.
Rodriguez, V.
Rossi, C.
Roue, G.
Lopez-Guillermo, A.
Gine, E.
Wiestner, A.
Bezombes, C.
Campo, E.
Colomer, D.
Balasubramanian, S.
Chiu, C.
Doshi, P.
Perez-Galan, P.
HAEMATOLOGICA, 2017, 102 : 563 - 563
[10] LAG-3 T-cell subsets in the tumor microenvironment of classical Hodgkin lymphoma and B-cell non-Hodgkin lymphoma
Takata, Katsuyoshi
CANCER SCIENCE, 2022, 113 : 1708 - 1708

← 1 2 3 4 5 →